These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4358602)

  • 1. [On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)].
    Válek J; Pechar J; Hrubá F
    Cas Lek Cesk; 1973 Dec; 112(49):1531-4. PubMed ID: 4358602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial type II hyperlipoproteinaemia. Clinical features and results of treatment in children and young adults.
    Stein EA; Mendelsohn D; Bersohn I
    S Afr Med J; 1974 Jan; 48(4):135-8. PubMed ID: 4363092
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
    Farah JR; Kwiterovich PO; Neill CA
    Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins].
    Vaverková H; Kubasta M; Zmeskal A; Procházka J; Vrublowský P; Podivínský
    Vnitr Lek; 1976 Jan; 22(1):73-83. PubMed ID: 175564
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of type II hyperlipoproteinaemia with cholestyramine.
    Schade RW; Laar A van't ; Jansen AP
    Neth J Med; 1973; 16(6):254-9. PubMed ID: 4767765
    [No Abstract]   [Full Text] [Related]  

  • 12. Homozygous type II hyperlipoproteinemia treatment. Partial ileal bypass in two children.
    Balfour JF; Kim R
    JAMA; 1974 Mar; 227(10):1145-51. PubMed ID: 4359836
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholestyramine: an effective, twice-daily dosage regimen.
    Blum CB; Havlik RJ; Morganroth J
    Ann Intern Med; 1976 Sep; 85(3):287-9. PubMed ID: 183576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portacaval shunt in hyperlipoproteinaemia.
    Starzl TE; Putnam CW; Chase HP; Porter KA
    Lancet; 1973 Oct; 2(7835):940-4. PubMed ID: 4126562
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 16. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Artery; 1982; 10(5):353-67. PubMed ID: 7181678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
    Fedele F
    Clin Ter; 2003; 154(4):231-6. PubMed ID: 14618939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis].
    Kolesár P
    Vnitr Lek; 1994 Feb; 40(2):89-92. PubMed ID: 8140767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesteremia. Treatment with cholestyramine, a bile acid sequestering resin.
    Casdorph HR
    Calif Med; 1967 Apr; 106(4):293-5. PubMed ID: 4859983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypercholesteremia with cholestyramine].
    Jacotot B; Beaumont V; Buxtorf JC; Le Parco JC; Beaumont JL
    Therapeutique; 1972 Mar; 48(3):225-30. PubMed ID: 4560997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.